Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …
Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …
Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems
VS Madamsetty, R Mohammadinejad… - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
COVID-19 and corticosteroids: a narrative review
G El-Saber Batiha, AI Al-Gareeb, HM Saad… - …, 2022 - Springer
It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …
[HTML][HTML] Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence
C Wagner, M Griesel, A Mikolajewska… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …
Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
P Mehta, DC Fajgenbaum - Current opinion in Rheumatology, 2021 - journals.lww.com
Hyperinflammation is a key component of severe COVID-19, residing underneath the
cytokine storm umbrella term, associated with poor outcomes. Better understanding of the …
cytokine storm umbrella term, associated with poor outcomes. Better understanding of the …
Innate immunity in protection and pathogenesis during coronavirus infections and COVID-19
RKS Malireddi, BR Sharma… - Annual Review of …, 2024 - annualreviews.org
The COVID-19 pandemic was caused by the recently emerged β-coronavirus SARS-CoV-2.
SARS-CoV-2 has had a catastrophic impact, resulting in nearly 7 million fatalities worldwide …
SARS-CoV-2 has had a catastrophic impact, resulting in nearly 7 million fatalities worldwide …
Treatment of MIS-C in children and adolescents
S Mahmoud, M El-Kalliny, A Kotby… - Current pediatrics …, 2022 - Springer
Abstract Purpose of Review Different treatment approaches have been described for the
management of COVID-19-related multisystem inflammatory syndrome in children (MIS-C) …
management of COVID-19-related multisystem inflammatory syndrome in children (MIS-C) …
COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges
Hyperactivation of immune responses resulting in excessive release of pro-inflammatory
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …